Heartflow, Inc.

HTFL ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023
Revenue $176.0M $125.8M $87.2M
Cost of Revenue $40.8M $31.4M $29.1M
Gross Profit $135.2M $94.4M $58.1M
Gross Margin 76.8% 75.1% 66.6%
Operating Expenses
Research & Development $64.9M $43.5M $35.9M
SG&A Expense $134.3M $112.2M $95.1M
Operating Income $-64.1M $-61.2M $-72.9M
Operating Margin -36.4% -48.7% -83.6%
Interest Expense
Pretax Income $-116.9M $-96.4M $-95.1M
Income Tax Expense $-76.0K $53.0K $547.0K
Net Income $-116.8M $-96.4M $-95.7M
Net Margin -66.3% -76.6% -109.7%
EPS (Basic) $-3.17 $-2.57 $-3.62
EPS (Diluted) $-3.17 $-2.57 $-3.62
Shares Outstanding (Basic) 85.8M 36.9M 37.5M 34.2M
Shares Outstanding (Diluted) 85.8M 36.9M 37.5M 34.2M
Dividends Per Share